Intrathecal Dexmedetomidine vs Midazolame - Trial NCT06315634

Name: Clinical Trial NCT06315634
Creator: National Cancer Institute, Egypt
Keywords: Postoperative Pain, Dexmedetomidine, Phase 4, drug, clinical trial, Egypt

Access comprehensive clinical trial information for NCT06315634 through Pure Global AI's free database. This Phase 4 trial is sponsored by National Cancer Institute, Egypt and is currently Completed. The study focuses on Postoperative Pain. Target enrollment is 75 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database

840K+ Trials

NCT06315634

Phase 4

Completed

drug

Trial Details

ClinicalTrials.gov • NCT06315634

View on ClinicalTrials.gov

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Intrathecal Dexmedetomidine vs Midazolame

Prospective Randomized Controlled Clinical Trial to Compare Intrathecal Dexmedetomidine Versus Midazolame in Orthopedic Cancer Surgeries

Study Focus

Disease/Condition

Postoperative Pain

Drug/Device/Intervention

Dexmedetomidine

Study Type

Interventional

Intervention Type

drug

Sponsor & Location

Primary Sponsor

National Cancer Institute, Egypt

Location

Cairo, Egypt

Timeline & Enrollment

Phase

Phase 4

Start Date

Mar 15, 2021

End Date

Mar 10, 2022

Enrollment

75 participants

Primary Outcome

Duration of sensory block

Summary

Prospective Randomized Controlled Clinical Trial to Compare Intrathecal Dexmedetomidine Versus Midazolame in Orthopedic Cancer Surgeries

ICD-10 Classifications

Acute pain

Postoperative intestinal obstruction

Pain, unspecified

During surgical operation

Data Source

Registry

ClinicalTrials.gov

Trial ID

NCT06315634

Type

Non-Device Trial